IL100241A - 6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it - Google Patents

6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it

Info

Publication number
IL100241A
IL100241A IL10024191A IL10024191A IL100241A IL 100241 A IL100241 A IL 100241A IL 10024191 A IL10024191 A IL 10024191A IL 10024191 A IL10024191 A IL 10024191A IL 100241 A IL100241 A IL 100241A
Authority
IL
Israel
Prior art keywords
adenosine
hydrate
methyl
cyclohexyl
myocardial infarction
Prior art date
Application number
IL10024191A
Other languages
English (en)
Other versions
IL100241A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL100241A0 publication Critical patent/IL100241A0/xx
Publication of IL100241A publication Critical patent/IL100241A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10024191A 1990-12-07 1991-12-05 6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it IL100241A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039060A DE4039060A1 (de) 1990-12-07 1990-12-07 Neue kristallform

Publications (2)

Publication Number Publication Date
IL100241A0 IL100241A0 (en) 1992-09-06
IL100241A true IL100241A (en) 1995-12-08

Family

ID=6419797

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10024191A IL100241A (en) 1990-12-07 1991-12-05 6-Cyclohexyl-2'-O-methyl-adenosine hydrate its preparation and pharmaceutical compositions containing it

Country Status (9)

Country Link
DE (1) DE4039060A1 (pl)
FI (1) FI915734A7 (pl)
IL (1) IL100241A (pl)
NO (1) NO178545C (pl)
NZ (1) NZ240873A (pl)
PL (1) PL166094B1 (pl)
SG (1) SG44937A1 (pl)
TW (1) TW224050B (pl)
ZA (1) ZA919658B (pl)

Also Published As

Publication number Publication date
NO178545C (no) 1996-04-17
FI915734L (fi) 1992-06-08
NO914779L (no) 1992-06-09
PL292665A1 (en) 1992-12-14
ZA919658B (en) 1993-06-27
NO178545B (no) 1996-01-08
FI915734A7 (fi) 1992-06-08
SG44937A1 (en) 1997-12-19
TW224050B (pl) 1994-05-21
PL166094B1 (pl) 1995-03-31
NZ240873A (en) 1993-09-27
FI915734A0 (fi) 1991-12-05
DE4039060A1 (de) 1992-06-11
NO914779D0 (no) 1991-12-05
IL100241A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
EP0490818B1 (en) 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof
CA2155673C (en) N-alkyl-2-substituted atp analogues
EP0920438B1 (en) N6 heterocyclic substituted adenosine derivatives
Hougen et al. Effects of inotropic and arrhythmogenic digoxin doses and of digoxin-specific antibody on myocardial monovalent cation transport in the dog.
US4621076A (en) Pharmaceutical composition useful for inhibiting platelet aggregation
US3823234A (en) Monohydrated papaverine adenosine-5'-monophosphate medicament for treatment of cardiovascular disorders
HU198950B (en) Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds
IT8948640A1 (it) Derivati dell'adenosina, loro preparazione e loro impiego come medicamenti. (caso 100-7409)
CA1092510A (en) Compositions containing 5'-amino-5' deoxythymidine and pharmaceutically acceptable salts thereof
CA1088944A (en) Nitric ester of n-(2-hydroxyethyl)nicotinamide and a process for the preparation of same
EP0266504A2 (en) Use of N6-[(1,2-dihydro-1-acenaphthylenyl) methyl]-adenosine in the preparation of pharmaceutical compounds for treating congestive heart failure
SK146096A3 (en) Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them
NO178545B (no) Fremgangsmåte for fremstilling av en adenosinforbindelse i ny krystallform
HRP920648A2 (en) New crystalline form
US4439442A (en) Naftidrofuryl citrate and therapeutic applications
JPH05504550A (ja) 免疫抑制剤として有用なピリミジン生合成インヒビター
JP3024789B2 (ja) 血圧降下剤
US4461891A (en) 2-β-D-Ribofuranosylthiazole-4-carboxamidine compounds
Nowak et al. Vascular effects of infused adenosine are not mediated by prostacyclin release in humans
Leone Jr et al. Adenosine deaminase and BW A1433U attenuate hypoxia-induced ventricular ectopy
MXPA96005046A (en) Derivatives of adenos
SK13192A3 (sk) Použitie 2'-0-alkyladenozínových derivátov na prípravu liečiva vhodného na liečenie neúrode generatívnych porúch
Kannan et al. Lack of Effect of 3, 3′ 5’-Triiodothyronine (Reverse T3) on Cardiac Function in the Rabbit
Erlemeier et al. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol
Schulz et al. Hypotensive and antiplatelet actions of motapizone depend on dose and time after ingestion

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees